Yvonne Bombard: Scaling access to precision medicine with Genetics Adviser

Yvonne Bombard shared a post by Elissa Levin, Founder of Elissa Levin Precision Medicine Innovation Consulting, on LinkedIn, adding the following:

“I may be biased but I agree! Genetics Adviser is growing! Join us to scale access to precision medicine. Genetics Adviser is the trusted digital platform that adapts to the diverse needs of patients, healthcare providers, and industry partners, facilitating high patient and clinician activation.

Delivering Precision Medicine + Genomics at scale with digital health.”

Quoting Elissa Levin’s post:

“Great opportunity to work an in incredible team!”

Yvonne Bombard is a Canada Research Chair at Unity Health Toronto and a Professor at the University of Toronto. She is also the CEO and Co-Founder of Genetics Adviser and a Research Scientist at the Li Ka Shing Knowledge Institute, St. Michael’s Hospital. Her research interests include genomics, health services, and policy research.